Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Tinazzi, Elisa ^a   Dolcino, Marzia ^b   Puccetti, Antonio ^b,c   Rigo, Antonella ^a   Beri, Ruggero ^a   Valenti, Maria T ^a   Corrocher, Roberto ^a   Lunardi, Claudio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST; VASODILATOR AGENT;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CIRCULATING ENDOTHELIAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INFUSION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ULCER; SYSTEMIC SCLEROSIS; UNINDEXED SEQUENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOLOGY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; MALE; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; REPRODUCIBILITY; STANDARD;

APOPTOSIS; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HUMANS; ILOPROST; MALE; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCLERODERMA, SYSTEMIC; SKIN ULCER; VASODILATOR AGENTS;

EID: 77954282503     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3069     Document Type: Article

References (58)

1. Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology 2009, 48:iii3-7. 10.1093/rheumatology/ken481, 19487220.
2. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, Haubitz M, Hebbel RP, Lip GY, Mancuso P, Sampol J, Solovey A, Dignat-george F. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005, 93:228-35.
3. Numaguchi Y, Sone T, Okumura K, Ishii M, Morita Y, Kubota R, Yokouchi K, Imai H, Harada M, Osanai H, Kondo T, Murohara T. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006, 114:I114-119. 10.1161/CIRCULATIONAHA.105.000588, 16820559.
4. Mancuso P, Burlini A, Pruneri G, Goldhirrsch A, Martinelli G, Bertolini F. Resting and activated endothelial cells are increate in the peripheral blood of cancer patients. Blood 2001, 97:3658-3661. 10.1182/blood.V97.11.3658, 11369666.
5. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999, 93:2951-2958.
6. Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W, Comina DP, Vitali C, Fantini F, Cortelezzi A. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004, 50:1296-1304. 10.1002/art.20116, 15077314.
7. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, Maglione W, Comina DP, Vitali C, Fraticelli P, Gabrielli A, Cortelezzi A, Lambertenghi-Deliliers G. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006, 54:2605-2615. 10.1002/art.22035, 16868984.
8. Woywodt A, Streiber F, De Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small vessel vasculitis. Lancet 2003, 361:206-210. 10.1016/S0140-6736(03)12269-6, 12547543.
9. Clarke LA, Shan V, Arrigoni F, Eleftherion D, Hong Y. Quantitative detection of circulating endothelial cells in vasculitis: comparison of flow cytometry and immunomagnetic bead extraction. J Thromb Haemost 2008, 6:1025-1032. 10.1111/j.1538-7836.2008.02953.x, 18363815.
10. Hristov M, Weber C. Endothelial progenitor cells in vascular repair and remodelling. Pharmacol Res 2008, 58:148-151. 10.1016/j.phrs.2008.07.008, 18722530.
11. Mariucci S, Rovati B, Chatzileontiadou S, Bencardino K, Manzoni M, Delfanti S, Danova M. A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells. Scand J Clin Lab Invest 2009, 69:433-438. 10.1080/00365510802673175, 19140086.
12. Liew A, Barry F, O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 2006, 28:261-270. 10.1002/bies.20372, 16479582.
13. Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 2006, 10:318-332. 10.1111/j.1582-4934.2006.tb00402.x, 16796802.
14. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967. 10.1126/science.275.5302.964, 9020076.
15. Hur J, Yang HM, Yoon CH, Lee CS, Park KW, Kim JH, Kim TY, Kim JY, Kang HJ, Chae IH, Oh BH, Park YB, Kim HS. Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 2007, 116:1671-1682. 10.1161/CIRCULATIONAHA.107.694778, 17909106.
16. Tanaka K, Sata M. Contribution of circulating vascular progenitors in lesion formation and vascular healing: lessons from animal models. Curr Opin Lipidol 2008, 19:498-504. 10.1097/MOL.0b013e32830dd566, 18769231.
17. Hristov M, Weber C. Ambivalence of progenitor cells in vascular repair and plaque stability. Curr Opin Lipidol 2008, 19:491-497. 10.1097/MOL.0b013e32830dfe33, 18769230.
18. Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, Yang Y, Becker MS, Zanetta L, Dejana E, Gasson JC, Tallquist MD, Iruela-Arispe ML. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3:625-636. 10.1016/j.stem.2008.09.018, 2631552, 19041779.
19. Krause W, Krais TH. Pharmacokinetics and pharmacodynamics of the prostacyclin analogue Iloprost in man. Eur J Clin Pharmacol 1986, 30:61-68. 10.1007/BF00614197, 2423342.
20. McHugh NJ, Csuka M, Watson H, Belcher G, Amadi A, Ring EF, Black CM, Maddison PJ. Infusion of iloprost a prostacyclin analogue for treatment of Raynaud's phenomenon in systemic sclerosis. Ann Rheum Dis 1988, 47:43-47. 10.1136/ard.47.1.43, 1003442, 2449871.
21. Keller J, Kaltenecker A, Schricher KT, Neidhart B, Hornstein OP. Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma. Arch Dermatol Res 1985, 277:323-325. 10.1007/BF00509089, 2408588.
22. He T, Lu T, d'Uscio LV, Lam C-F, Lee H-C, Katusic ZS. Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells. Circ Res 2008, 103:80-88. 10.1161/CIRCRESAHA.108.176057, 2664088, 18511850.
23. Stratton R, Shiven X, Martini G, Holmes A, Leask A, Haberberger T, Martin GR, Black CM, Abraham D. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001, 108:241-250. 203022, 11457877.
24. Kamio K, Sato T, Liu X, Sugiura H, Togo S, Kobayashi T, Kawasaki S, Wang X, Mao L, Ahn Y, Holz O, Magnussen H, Rennard SI. Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture. Am J Physiol Lung Cell Mol Physiol 2008, 294:L1226-1232. 10.1152/ajplung.00129.2007, 18424619.
25. Hata AN, Allen MA. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 2004, 103:147-166. 10.1016/j.pharmthera.2004.06.003, 15369681.
26. Bulin C, Albrecht U, Bode JG, Weber A, Schrör K, Levkau B, Fisher JW. Differential effects of vasodilatatory Prostaglandins on focal adhesions cytoskeletal architeture and migration in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2005, 25:84-89.
27. Aronoff DM, Peres CM, Serezani CH, Ballinger MN, Carstens JK, Coleman N, Moore BB, Stokes Peebles R, Faccioli LH, Peters-Golden M. Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities. J Immunol 2007, 178:1628-1634.
28. Gratama JW, Keeney M, Sutherland DR. Enumeration of CD34 + hematopoietic stem and progenitor cells. Current Protocols in Cytometry 2003, (Suppl 25). Unit 6.4.
29. Khan SS, Solomon MA, McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005, 64:1-8.
30. Gratama JW, Braakman E, Kraan J, Lankheet P, Levering WH, Van Den Beemd MW, Van Der Schoot CE, Wijermans P, Preijers F. Comparison of single and dual platformassay format for CD34 + haematopoietic progenitor cell enumeration. Clin Lab Haemotol 1999, 21:337-346.
31. Designing Estimators for Low Level Expression Analysis. , http://mbi.osu.edu/2004/ws1abstracts.html
32. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.
33. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affimetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15. 10.1093/nar/gng015, 150247, 12582260.
34. Lunardi C, Dolcino M, Peterlana D, Bason C, Navone R, Tamassia N, Beri R, Corrocher R, Puccetti A. Antibodies against human citomegalovirus in the pathogenesis of sistemic sclerosis: a gene array approach. PLoS Med 2006, 3:e2. 10.1371/journal.pmed.0030002, 1298939,1298939, 16318412.
35. The gene ontology. , http://www.geneontology.org/
36. Hu Y, Hines LM, Weng H, Zuo D, Rivera M, Richardson A, LaBaer J. Analysis of genomic and proteomic data using advanced literature mining. J Proteome Res 2003, 2:405-412. 10.1021/pr0340227, 12938930.
37. Heid CA, Stevens J, Livak KJ, Williams PM. Real Time quantitative PCR. Genome Res. 1996, 6:986-994.
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-delta delta Ct) method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
39. Jacques N, Vimond N, Conforti R, Griscielli F, Lescluse Y, Laplanche A, Malka D, Vielh P, Farace F. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometry assay. J Immunol Methods 2008, 15:132-143.
40. Redondo S, Hristov M, Gordillo-Moscoso AA, Ruiz E, Weber C, Tejerina T. High reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34 +/CD144 +/CD3- lymphocyte sub-population. J Immunol Methods 2008, 335:21-27. 10.1016/j.jim.2008.02.011, 18402976.
41. Dignat-George F, Sabatier F, Blann A, Woywodt A. Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?. J Clin Oncol 2007, 25:e1-e2. 10.1200/JCO.2006.07.7677, 17290051.
42. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, Akhmetshina A, Walker UA, Gabrielli A, Muller-Ladner U, Tyndall A, Matucci-Cerinic M, Distler O, . EULAR Scleroderma Trials and Research group EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009, 68:163-168. 10.1136/ard.2008.091918, 18653485, EULAR Scleroderma Trials and Research group.
43. Kuwana M, Kaburaki J, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum 2006, 54:1946-1951. 10.1002/art.21899, 16729283.
44. Zhu S, Evans S, Yan B, Povsic TJ, Tapson V, Goldschmidt-Clermont PJ, Dong C. Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation 2008, 118:2156-2165. 10.1161/CIRCULATIONAHA.108.787200, 18981303.
45. Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y. Circulating endothelial progeniotor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008, 67:1455-1460. 10.1136/ard.2007.082131, 18174219.
46. Liu D, Yang X, Songyang Z. Identification of CISK a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr Biol 2000, 10:1233-1236. 10.1016/S0960-9822(00)00733-8, 11050396.
47. Kuiper EJ, Hughes JM, Van Geest RJ, Vogels IM, Goldschmeding R, Van Noorden CJ, Schlingemann RO, Klaassen I. Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina. Invest Ophthalmol Vis Sci 2007, 48:4267-4276. 10.1167/iovs.06-0804, 17724216.
48. Dean RA, Butler GS, Hamma-Kourbali Y, Delbè J, Brigstock DR, Courty J, Overall CM. Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol 2007, 27:8454-8465. 10.1128/MCB.00821-07, 2169415, 17908800.
49. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 2002, 5:153-165. 10.1023/A:1023823803510, 12831056.
50. Cicha I, Yilmaz A, Klein M, Raithel D, Brigstock DR, Daniel WG, Goppel-Struebe M, Garlichs CD. Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2005, 25:1008-1013. 10.1161/01.ATV.0000162173.27682.7b, 15761189.
51. Cipriani P, Franca Milia A, Liakouli V, Pacini A, Manetti M, Marrelli A, Toscano A, Pingiotti E, Fulminis A, Guiducci S, Perricone R, Kahaleh B, Matucci-Cerinic M, Ibba-Maneschi L, Giacomelli R. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenic implications. Arthritis Rheum 2006, 54:3022-3033. 10.1002/art.22047, 16948134.
52. Beadry P, Hida Y, Udagawa T, Alwayn IP, Greene AK, Arsenault D, Folkman J, Heymach JV, Ryeom S, Puder M. Endothelial progenitor cells contribute to accelerate liver regeneration. J Pediatr Surg 2007, 42:1190-1198. 10.1016/j.jpedsurg.2007.02.034, 17618879.
53. Ferreira LS, Gerecht S, Shieh HF, Watson N, Rupnick MA, Dallabrida SM, Vunjak-Novakovic G, Langer R. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle-like cells and form vascular networks in vivo. Circ Res 2007, 101:286-294. 10.1161/CIRCRESAHA.107.150201, 17569886.
54. Stratton R, Rajkumar V, Ponticos M, Nichols B, Shiwen X, Black CM, Abraham DJ, Leask A. Prostacyclin derivates prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway. FASEB J 2002, 16:1949-1951.
55. Lederle FA, Nelson DB, Joseph AM. Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg 2003, 38:329-334. 10.1016/S0741-5214(03)00136-8, 12891116.
56. Solanilla A, Villenueve J, Auguste P, Hugues M, Alioum A, Lepreux S, Ducroix JP, Duhaut P, Conri C, Viallard JF, Nurden AT, Constans J, Ripoche J. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis. Rheumatology 2009, 48:1036-1044. 10.1093/rheumatology/kep154, 19549789.
57. Giusti B, Fibbi G, Marheri F, Serrati S, Rossi L, Poggi F, Lapini I, Magi A, Del Rosso A, Cinelli M, Guiducci S, Kahaleh B, Bazzicchi L, Bombardieri S, Matucci-Cerinic M, Gensini GF, Del Rosso M, Abbate R. A model of anti-angiogenesis: differential trasncriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. Arthritis Res Ther 2006, 8:R115. 10.1186/ar2002, 1779372, 16859528.
58. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, Whitfield ML. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 2008, 3:e2696. 10.1371/journal.pone.0002696, 2481301, 18648520.